Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: CHILDREN'S HOSPITAL CORPORATION, THE
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-09-30 to 2025-09-29
Current total value of award: $19894862
Description: TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL.